The global Enzyme Replacement Therapy market size was valued at US$ 15790 million in 2024 and is forecast to a readjusted size of USD 38350 million by 2031 with a CAGR of 13.7% during review period.
Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.
Global Enzyme Replacement Therapy key players include Johnson & Johnson, Allergan, AbbVie, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 70%, followed by Europe, and Asia-Pacific, both have a share over 25 percent.
In terms of product, Oral Agents is the largest segment, with a share nearly 95%. And in terms of application, the largest application is MPS Disease, followed by Gastrointestinal Diseases, Gaucher Disease, Fabry Disease, etc.
This report is a detailed and comprehensive analysis for global Enzyme Replacement Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Enzyme Replacement Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Enzyme Replacement Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Enzyme Replacement Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Enzyme Replacement Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enzyme Replacement Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enzyme Replacement Therapy market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Enzyme Replacement Therapy market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Injectable Agents
Oral Agents
麻豆原创 segment by Application
Gaucher Disease
Fabry Disease
MPS Disease
Gastrointestinal Disease
Others
Major players covered
Sanofi
Takeda
BioMarin
AbbVie
Alexion
Allergan
Horizon Pharma
Johnson & Johnson
Actelion
Recordati Rare Diseases
Pfizer
Digestive Care
Leadiant Biosciences
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enzyme Replacement Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enzyme Replacement Therapy, with price, sales quantity, revenue, and global market share of Enzyme Replacement Therapy from 2020 to 2025.
Chapter 3, the Enzyme Replacement Therapy competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enzyme Replacement Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Enzyme Replacement Therapy market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enzyme Replacement Therapy.
Chapter 14 and 15, to describe Enzyme Replacement Therapy sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Enzyme Replacement Therapy Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Injectable Agents
1.3.3 Oral Agents
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Enzyme Replacement Therapy Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Gaucher Disease
1.4.3 Fabry Disease
1.4.4 MPS Disease
1.4.5 Gastrointestinal Disease
1.4.6 Others
1.5 Global Enzyme Replacement Therapy 麻豆原创 Size & Forecast
1.5.1 Global Enzyme Replacement Therapy Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Enzyme Replacement Therapy Sales Quantity (2020-2031)
1.5.3 Global Enzyme Replacement Therapy Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Enzyme Replacement Therapy Product and Services
2.1.4 Sanofi Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Sanofi Recent Developments/Updates
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Enzyme Replacement Therapy Product and Services
2.2.4 Takeda Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Takeda Recent Developments/Updates
2.3 BioMarin
2.3.1 BioMarin Details
2.3.2 BioMarin Major Business
2.3.3 BioMarin Enzyme Replacement Therapy Product and Services
2.3.4 BioMarin Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 BioMarin Recent Developments/Updates
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Enzyme Replacement Therapy Product and Services
2.4.4 AbbVie Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 AbbVie Recent Developments/Updates
2.5 Alexion
2.5.1 Alexion Details
2.5.2 Alexion Major Business
2.5.3 Alexion Enzyme Replacement Therapy Product and Services
2.5.4 Alexion Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Alexion Recent Developments/Updates
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Enzyme Replacement Therapy Product and Services
2.6.4 Allergan Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Allergan Recent Developments/Updates
2.7 Horizon Pharma
2.7.1 Horizon Pharma Details
2.7.2 Horizon Pharma Major Business
2.7.3 Horizon Pharma Enzyme Replacement Therapy Product and Services
2.7.4 Horizon Pharma Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Horizon Pharma Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Enzyme Replacement Therapy Product and Services
2.8.4 Johnson & Johnson Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Actelion
2.9.1 Actelion Details
2.9.2 Actelion Major Business
2.9.3 Actelion Enzyme Replacement Therapy Product and Services
2.9.4 Actelion Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Actelion Recent Developments/Updates
2.10 Recordati Rare Diseases
2.10.1 Recordati Rare Diseases Details
2.10.2 Recordati Rare Diseases Major Business
2.10.3 Recordati Rare Diseases Enzyme Replacement Therapy Product and Services
2.10.4 Recordati Rare Diseases Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Recordati Rare Diseases Recent Developments/Updates
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Enzyme Replacement Therapy Product and Services
2.11.4 Pfizer Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Pfizer Recent Developments/Updates
2.12 Digestive Care
2.12.1 Digestive Care Details
2.12.2 Digestive Care Major Business
2.12.3 Digestive Care Enzyme Replacement Therapy Product and Services
2.12.4 Digestive Care Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Digestive Care Recent Developments/Updates
2.13 Leadiant Biosciences
2.13.1 Leadiant Biosciences Details
2.13.2 Leadiant Biosciences Major Business
2.13.3 Leadiant Biosciences Enzyme Replacement Therapy Product and Services
2.13.4 Leadiant Biosciences Enzyme Replacement Therapy Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Leadiant Biosciences Recent Developments/Updates
3 Competitive Environment: Enzyme Replacement Therapy by Manufacturer
3.1 Global Enzyme Replacement Therapy Sales Quantity by Manufacturer (2020-2025)
3.2 Global Enzyme Replacement Therapy Revenue by Manufacturer (2020-2025)
3.3 Global Enzyme Replacement Therapy Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Enzyme Replacement Therapy by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Enzyme Replacement Therapy Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Enzyme Replacement Therapy Manufacturer 麻豆原创 Share in 2024
3.5 Enzyme Replacement Therapy 麻豆原创: Overall Company Footprint Analysis
3.5.1 Enzyme Replacement Therapy 麻豆原创: Region Footprint
3.5.2 Enzyme Replacement Therapy 麻豆原创: Company Product Type Footprint
3.5.3 Enzyme Replacement Therapy 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Enzyme Replacement Therapy 麻豆原创 Size by Region
4.1.1 Global Enzyme Replacement Therapy Sales Quantity by Region (2020-2031)
4.1.2 Global Enzyme Replacement Therapy Consumption Value by Region (2020-2031)
4.1.3 Global Enzyme Replacement Therapy Average Price by Region (2020-2031)
4.2 North America Enzyme Replacement Therapy Consumption Value (2020-2031)
4.3 Europe Enzyme Replacement Therapy Consumption Value (2020-2031)
4.4 Asia-Pacific Enzyme Replacement Therapy Consumption Value (2020-2031)
4.5 South America Enzyme Replacement Therapy Consumption Value (2020-2031)
4.6 Middle East & Africa Enzyme Replacement Therapy Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Enzyme Replacement Therapy Sales Quantity by Type (2020-2031)
5.2 Global Enzyme Replacement Therapy Consumption Value by Type (2020-2031)
5.3 Global Enzyme Replacement Therapy Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Enzyme Replacement Therapy Sales Quantity by Application (2020-2031)
6.2 Global Enzyme Replacement Therapy Consumption Value by Application (2020-2031)
6.3 Global Enzyme Replacement Therapy Average Price by Application (2020-2031)
7 North America
7.1 North America Enzyme Replacement Therapy Sales Quantity by Type (2020-2031)
7.2 North America Enzyme Replacement Therapy Sales Quantity by Application (2020-2031)
7.3 North America Enzyme Replacement Therapy 麻豆原创 Size by Country
7.3.1 North America Enzyme Replacement Therapy Sales Quantity by Country (2020-2031)
7.3.2 North America Enzyme Replacement Therapy Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Enzyme Replacement Therapy Sales Quantity by Type (2020-2031)
8.2 Europe Enzyme Replacement Therapy Sales Quantity by Application (2020-2031)
8.3 Europe Enzyme Replacement Therapy 麻豆原创 Size by Country
8.3.1 Europe Enzyme Replacement Therapy Sales Quantity by Country (2020-2031)
8.3.2 Europe Enzyme Replacement Therapy Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Enzyme Replacement Therapy Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Enzyme Replacement Therapy Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Enzyme Replacement Therapy 麻豆原创 Size by Region
9.3.1 Asia-Pacific Enzyme Replacement Therapy Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Enzyme Replacement Therapy Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Enzyme Replacement Therapy Sales Quantity by Type (2020-2031)
10.2 South America Enzyme Replacement Therapy Sales Quantity by Application (2020-2031)
10.3 South America Enzyme Replacement Therapy 麻豆原创 Size by Country
10.3.1 South America Enzyme Replacement Therapy Sales Quantity by Country (2020-2031)
10.3.2 South America Enzyme Replacement Therapy Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Enzyme Replacement Therapy Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Enzyme Replacement Therapy Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Enzyme Replacement Therapy 麻豆原创 Size by Country
11.3.1 Middle East & Africa Enzyme Replacement Therapy Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Enzyme Replacement Therapy Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Enzyme Replacement Therapy 麻豆原创 Drivers
12.2 Enzyme Replacement Therapy 麻豆原创 Restraints
12.3 Enzyme Replacement Therapy Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Enzyme Replacement Therapy and Key Manufacturers
13.2 Manufacturing Costs Percentage of Enzyme Replacement Therapy
13.3 Enzyme Replacement Therapy Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Enzyme Replacement Therapy Typical Distributors
14.3 Enzyme Replacement Therapy Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Sanofi
Takeda
BioMarin
AbbVie
Alexion
Allergan
Horizon Pharma
Johnson & Johnson
Actelion
Recordati Rare Diseases
Pfizer
Digestive Care
Leadiant Biosciences
听
听
*If Applicable.
